HOME >> BIOLOGY >> NEWS
New prime-boost HIV vaccine strategy shows promise in monkeys

ter vaccination and then infected all the macaques with a high dose of SHIV. "Most other studies challenge after several weeks," says Dr. Moss, "but a vaccine that only protects for a short time is not very helpful. We extended the post-vaccination time to check long-term efficacy." Dr. Moss also stresses another important feature of their vaccine strategy: the monkeys were infected by applying the virus in the rectum. "The majority of HIV infections occur when the virus crosses mucous membranes, so we needed to see if our vaccine would work against this route of infection."

Although all 28 monkeys were infected, the vaccinated monkeys showed lower initial SHIV levels and quickly began to suppress the virus further. Twenty weeks after infection, the amount of virus in the bloodstream of the vaccinated monkeys was on average 2,000 times lower than controls. The researchers continue to monitor virus levels in these animals.

"These are among the very best outcomes we have seen in an animal model," says Peggy Johnston, Ph.D., NIAID's assistant director for HIV vaccines, "and we are using NIH's developmental resources and the HIV Vaccine Trials Network (HVTN) to move these and other promising vaccines into human trials in the United States and elsewhere as quickly as possible."

Both teams have already constructed HIV versions of the DNA and MVA vaccines, and human clinical trials are currently planned for the coming year. The rapid progress of these products and their future entry into clinical trials is being supported by NIAID through a range of programs put into place to fast-track HIV vaccines through the various stages of basic and preclinical research, product development and production, and clinical trials.


'"/>

Contact: Gregory Roa
greg.roa@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
7-Mar-2001


Page: 1 2 3

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
3. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Protective gene may enhance vaccine responses
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. New glycan arrays discover autoimmunogenic activities of SARS-CoV: concern over monkey vaccine
8. Growing new breed of vaccine-producing plants to fight human diseases worldwide
9. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
10. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
11. Herpes tool allows researchers to customize Alzheimers vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):
(Date:9/12/2017)... ... September 12, 2017 , ... September 15, ... that Jeremy Nicholson, Head of the Department of Surgery and Cancer and Director ... Wallace H. Coulter Lecture. His presentation, “Analytical Science in Precision Medicine: Facing ...
(Date:9/12/2017)... ... September 12, 2017 , ... Facet Life Sciences, a ... teams, today announced that Tobias Massa, PhD has joined the company’s Board of Directors. ... and technology to his Board position. Most recently he served as VP and Head ...
(Date:9/12/2017)... (PRWEB) , ... September 11, 2017 , ... ... health and financial burden associated with Sepsis, BD is sponsoring an educational webinar ... estimated 31 Million people worldwide, with an estimated five million deaths annually, is ...
(Date:9/12/2017)... ... September 12, 2017 , ... ... that accelerate pharmaceutical and biotherapeutics development, announces a new publication in ... R100 biosensor. Antibodies developed by the Centers for Disease Control (CDC) were used ...
Breaking Biology Technology:
Cached News: